Imagion Biosystems announces new appointment to the Board of Directors

Imagion Biosystems (ASX: $IBX) has appointed Mr Brett Mitchell as a Non-Executive Director, effective 14 June 2024. Mr Mitchell brings over 15 years of experience in corporate finance, particularly in ASX listed companies within biopharmaceutical, mining, energy, and tech industries.

Executive and Board's Comments on the Appointment

Mr. Mitchell expressed his enthusiasm about joining the Imagion Biosystems Board, citing his belief in contributing to the company's reestablishment and value creation through its innovative medical imaging technology. Executive Chairman, Bob Proulx, welcomed Mr. Mitchell, highlighting the value of his experience in the ASX capital markets for the company's future endeavors.

Summary of Imagion Biosystems' Appointment and Future Expectations

Imagion Biosystems (ASX: $IBX) has appointed Mr Brett Mitchell as a Non-Executive Director, aiming to benefit from his extensive experience in corporate finance and ASX listed companies. The appointment is expected to aid the company in its path forward, potentially leading to the reinstatement of IBX to official quotation, allowing trading to resume. Additionally, the Company intends to hold a meeting as required to reelect the Board of Directors, indicating a strategic move towards reinforcing the leadership. With a focus on revolutionizing cancer diagnosis through innovative medical imaging technologies, Imagion Biosystems is poised to leverage Mr. Mitchell's expertise to advance its clinical development and achieve its corporate goals.